Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi

Despite improvements in standard therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone for patients with untreated, diffuse large B-cell lymphoma, up to 40% of these patients relapse. Lenalidomide alone or in combination with rituximab has been shown to be active in relap...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Chiappella, Annalisa, Tucci, Alessandra, Castellino, Alessia, Pavone, Vincenzo, Baldi, Ileana, Carella, Angelo Michele, Orsucci, Lorella, Zanni, Manuela, Salvi, Flavia, Liberati, Anna Marina, Gaidano, Gianluca, Bottelli, Chiara, Rossini, Bernardo, Perticone, Sonia, De Masi, Pasqualina, Ladetto, Marco, Ciccone, Giovannino, Palumbo, Antonio, Rossi, Giuseppe, Vitolo, Umberto
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Ferrata Storti Foundation 2013
Aiheet:
Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3815174/
https://ncbi.nlm.nih.gov/pubmed/23812930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2013.085134
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia